Background: The prognostic impact of catheter ablation (CA) of atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients has not yet been satisfactorily elucidated. Objectives: The aim of the study was to assess the impact of CA of AF on clinical outcomes in a large cohort of HCM patients. Methods: In this retrospective multicenter study, 555 HCM patients with AF were enrolled, 140 undergoing CA and 415 receiving medical therapy. 1:1 propensity score matching led to the inclusion of 226 patients (113 medical group, 113 intervention group) in the final analysis. The primary outcome was a composite of all-cause mortality, heart transplant and acute heart failure exacerbations. Secondary outcomes included AF recurrence and transition to permanent AF. Additionally, an inverse probability weighted (IPW) model was examined. Results: At propensity score matching analysis, after a median follow-up of 58.1 months, the primary endpoint occurred in 29 (25.7%) patients in intervention group vs 42 (37.2%) in medical group (P = 0.9). Thromboembolic strokes and major arrhythmic events in intervention vs medical group were 9.7% vs 7.1% (P = 0.144) and 4.4 vs 8.0% (P = 0.779), respectively. Fewer patients in intervention vs medical group experienced AF recurrences (63.7% vs 84.1%, P = 0.001) and transition to permanent AF pattern (20.4% vs 33.6%, P = 0.026). IPW analysis showed consistent results. Severe complications related to CA were uncommon (0.7%). Conclusions: After 5 years of follow-up, CA did not improve major adverse cardiac outcomes in a large cohort of patients with HCM and AF. Nevertheless, CA seems to facilitate the maintenance of sinus rhythm and slow the progression to permanent AF, without significant safety concerns.

Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based Analysis / Pierri, Alessandro; Albani, Stefano; Merlo, Marco; Buongiorno, Antonia Luisa; Ricotti, Andrea; Grilli, Giulia; Barbisan, Davide; Grossi, Stefano; De Rosa, Catia; Mabritto, Barbara; Luceri, Stefania; Bongioanni, Sergio; Negri, Francesco; Burelli, Massimo; Millesimo, Michele; Biondi, Federico; Cireddu, Manuela; Berg, Jan; Musumeci, Maria Beatrice; Di Donna, Paolo; Vianello, Pier Filippo; Del Franco, Annamaria; Scaglione, Marco; Barbati, Giulia; Urru, Sara; Berchialla, Paola; De Ferrari, Gaetano Maria; Russo, Vincenzo; Agricola, Eustachio; Imazio, Massimo; Porto, Italo; Canepa, Marco; Peretto, Giovanni; Francia, Pietro; Castagno, Davide; Autore, Camillo; Olivotto, Iacopo; Gaita, Fiorenzo; Sinagra, Gianfranco; Musumeci, Giuseppe. - In: JACC. ADVANCES. - ISSN 2772-963X. - ELETTRONICO. - 3:(2024), pp. 1-13. [10.1016/j.jacadv.2024.100899]

Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based Analysis

Ricotti, Andrea;Del Franco, Annamaria;Berchialla, Paola;Olivotto, Iacopo;
2024

Abstract

Background: The prognostic impact of catheter ablation (CA) of atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients has not yet been satisfactorily elucidated. Objectives: The aim of the study was to assess the impact of CA of AF on clinical outcomes in a large cohort of HCM patients. Methods: In this retrospective multicenter study, 555 HCM patients with AF were enrolled, 140 undergoing CA and 415 receiving medical therapy. 1:1 propensity score matching led to the inclusion of 226 patients (113 medical group, 113 intervention group) in the final analysis. The primary outcome was a composite of all-cause mortality, heart transplant and acute heart failure exacerbations. Secondary outcomes included AF recurrence and transition to permanent AF. Additionally, an inverse probability weighted (IPW) model was examined. Results: At propensity score matching analysis, after a median follow-up of 58.1 months, the primary endpoint occurred in 29 (25.7%) patients in intervention group vs 42 (37.2%) in medical group (P = 0.9). Thromboembolic strokes and major arrhythmic events in intervention vs medical group were 9.7% vs 7.1% (P = 0.144) and 4.4 vs 8.0% (P = 0.779), respectively. Fewer patients in intervention vs medical group experienced AF recurrences (63.7% vs 84.1%, P = 0.001) and transition to permanent AF pattern (20.4% vs 33.6%, P = 0.026). IPW analysis showed consistent results. Severe complications related to CA were uncommon (0.7%). Conclusions: After 5 years of follow-up, CA did not improve major adverse cardiac outcomes in a large cohort of patients with HCM and AF. Nevertheless, CA seems to facilitate the maintenance of sinus rhythm and slow the progression to permanent AF, without significant safety concerns.
2024
3
1
13
Pierri, Alessandro; Albani, Stefano; Merlo, Marco; Buongiorno, Antonia Luisa; Ricotti, Andrea; Grilli, Giulia; Barbisan, Davide; Grossi, Stefano; De R...espandi
File in questo prodotto:
File Dimensione Formato  
musumeci-et-al-2024-transcatheter-ablation-of-atrial-fibrillation-in-patients-with-hypertrophic-cardiomyopathy.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 1.4 MB
Formato Adobe PDF
1.4 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1404737
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact